Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Terlipressin Injection

Approval Number

国药准字H20223621

Company海南普利制药股份有限公司

Registration Date

August 30, 2022

Drug Information

Generic Name

特利加压素注射液

Dosage Form

注射剂

Strength

8.5ml :0.85mg（按C₅₂H₇₄N₁₆O₁₅S₂计）

Drug Type

化学药品

Registration Date

August 30, 2022

Company Information

Applicant Company

Company Name海南普利制药股份有限公司

Company Address

海口市美兰区桂林洋经济开发区

Manufacturing Company

Company Name海南普利制药股份有限公司

Company Address

海口市美兰区桂林洋经济开发区

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy